Articles

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia

Division of Hematology, The Ottawa Hospital, ON, Canada
Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, USA
Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, USA;Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
Armed Forces Bone Marrow Transplant Center, Rawalpindi, Pakistan
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Instituto Nacional de Câncer, Rio de Janeiro, Brazil
Department of Pediatric Hematology/Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
Department of Pediatrics, University Medical Center Utrecht, The Netherlands
Hospital de Clinicas, Federal University of Parana, Curitiba, Brazil
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Division of Hematology, Oncology and Blood & Marrow Transplantation, Children’s Hospital Los Angeles, CA, USA
BMT Center, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea
Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA
Division of Hematology, Oncology and Blood & Marrow Transplantation, Children’s Hospital Los Angeles, CA, USA
Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA
Vol. 102 No. 7 (2017): July, 2017 https://doi.org/10.3324/haematol.2017.164459